Literature DB >> 12686824

Fracture risk following bilateral orchiectomy.

L Joseph Melton1, Khalid I Alothman, Sundeep Khosla, Sara J Achenbach, Ann L Oberg, Horst Zincke.   

Abstract

PURPOSE: Bone loss has been reported in patients with prostate cancer treated with androgen deprivation therapy. We assess fracture risk following bilateral orchiectomy.
MATERIALS AND METHODS: Through the Rochester Epidemiology Project we identified 429 Olmsted County, Minnesota men who underwent bilateral orchiectomy in 1956 to 2000, almost all for prostate cancer. Fractures were ascertained from comprehensive medical records and compared with expected numbers based on local incidence rates (standardized incidence ratio, SIR). Potential risk factors were assessed with proportional hazards models.
RESULTS: During 1961 person-years of followup 161 men experienced 267 fractures, for a cumulative incidence after 15 years of 40% compared to 19% expected (p <0.001). However, 42 were pathological fractures and 82 were found incidentally on radiological surveys for metastasis. Overall fracture risk was increased (SIR 3.42, 95% CI 2.91-3.99) but was reduced by excluding the pathological and incidental fractures (SIR 2.04, 95% CI 1.66-2.47). The increase was largely accounted for by the moderate trauma fractures of the hip, spine and distal forearm traditionally linked with osteoporosis (SIR 3.50, 95% CI 2.71-4.43). In multivariate analyses risk factors for fractures generally included patient age, inactivity, prior radiological diagnosis of osteoporosis, chemotherapy and use of nonsteroidal antiandrogens, while independent risk factors for the traditional osteoporotic fractures included age, inactivity and diagnosis of osteoporosis.
CONCLUSIONS: Fractures are common in men with prostate cancer due to advanced age, occurrence of pathological fractures and enhanced skeletal surveillance but there remains a significant increase in osteoporotic fracture risk following bilateral orchiectomy.

Entities:  

Mesh:

Year:  2003        PMID: 12686824     DOI: 10.1097/01.ju.0000059281.67667.97

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  31 in total

Review 1.  Male osteoporosis: new trends in diagnosis and therapy.

Authors:  Hosam K Kamel
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Fracture risk in patients with prostate cancer on androgen deprivation therapy.

Authors:  Ana M López; María A Pena; Rafael Hernández; Fernando Val; Bernardo Martín; José A Riancho
Journal:  Osteoporos Int       Date:  2005-02-16       Impact factor: 4.507

3.  Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats.

Authors:  Yankel Gabet; David Kohavi; Ralph Müller; Michael Chorev; Itai Bab
Journal:  Osteoporos Int       Date:  2005-04-06       Impact factor: 4.507

4.  Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.

Authors:  C-T Wu; Y-H Yang; P-C Chen; M-F Chen; W-C Chen
Journal:  Osteoporos Int       Date:  2015-05-20       Impact factor: 4.507

Review 5.  Cancer therapies and bone health.

Authors:  Mimi I Hu; Huifang Lu; Robert F Gagel
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

Review 6.  Treatment-related osteoporosis in men with prostate cancer.

Authors:  Matthew R Smith
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

Review 7.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

8.  FRAX assessment of osteoporotic fracture probability in Switzerland.

Authors:  K Lippuner; H Johansson; J A Kanis; R Rizzoli
Journal:  Osteoporos Int       Date:  2009-06-11       Impact factor: 4.507

9.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

10.  Prostate cancer and osteoporosis.

Authors:  Stephen P Tuck; Birgit Hanusch; Julie Walker; Harish K Datta
Journal:  Curr Osteoporos Rep       Date:  2013-03       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.